Studies have reported that soluble ULBP2, as a ligand of NKG2D, suppresses the expression of NKG2D and inhibits NK cell activity, thereby allowing tumor cells to escape immune surveillance and promoting immune evasion (42). This evidence concerns the gene KLRK1 and neoplasm.